Rivaroxaban attenuates neutrophil maturation in the bone marrow niche

Pharmacological inhibition of factor Xa by rivaroxaban has been shown to mediate cardioprotection and is frequently used in patients with, e.g., atrial fibrillation. Rivaroxaban's anti-inflammatory actions are well known, but the underlying mechanisms are still incompletely understood. To date,...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneckmann, R., Döring, M., Gerfer, S., Gorressen, S., Heitmeier, S., Helten, C., Polzin, A., Jung, C., Kelm, M., Fender, A. C., Flögel, U., Grandoch, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Contribution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425524/
https://www.ncbi.nlm.nih.gov/pubmed/37580509
http://dx.doi.org/10.1007/s00395-023-01001-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425524/
https://www.ncbi.nlm.nih.gov/pubmed/37580509
http://dx.doi.org/10.1007/s00395-023-01001-5

Ejemplares similares